Home > SWOT Analysis > Genentech (DNA) SWOT Analysis

Genentech (DNA) SWOT Analysis Profile

Genentech, Inc. discovers and manufactures pharmaceutical products for the treatment of such diseases as colon cancer, non-Hodgkins lymphoma, breast cancer, age-related macular degeneration, asthma, growth hormone deficiency, heart attacks, blood clots, cystic fibrosis, and plaque psoriasis. The company collaborates with a number of research and pharmaceutical firms and sells products to specialty distributors and pharmacies. (read full profile)

Additional Information

What is a SWOT Analysis? It is a way of evaluating the strengths, weaknesses, opportunities, and threats that affect something. See WikiWealth's SWOT tutorial for help. Remember, vote up the most important comments. Check out WikiWealth's entire database of free SWOT reports or use our SWOT analysis generator to create your own SWOT template.

Receive News & Ratings Via Email

Free Email Newsletter

SWOT Conclusion

Strengths + Opportunities = 5

Threats + Weaknesses = 4

… The ability to capitalize on opportunities get rewarded with higher profits and lower costs. A good defense against threats lowers the risks that profits will decrease. Maintaining strengths can help maintain high profits and low costs.